Showing results (271-280 of 875) with videos related to
Sort By:
Pageof 88
Gastrointestinal Endoscopy Clinics of North America|June 6, 2013
Endomicroscopy and endocytoscopy in IBDHelmut Neumann, Ralf KiesslichJournal of Crohn'S & Colitis|May 22, 2016
Clinical Effects of a Topically Applied Toll-like Receptor 9 Agonist in Active Moderate-to-Severe Ulcerative ColitisRaja Atreya, Stuart Bloom, Franco Scaldaferri, et al.Cells|September 28, 2021
Dynamic, Transient, and Robust Increase in the Innervation of the Inflamed Mucosa in Inflammatory Bowel DiseasesMiguel Gonzalez Acera, Marvin Bubeck, Fabrizio Mascia, et al.Journal of Crohn'S & Colitis|August 4, 2016
Phase 1 Clinical Study of siRNA Targeting Carbohydrate Sulphotransferase 15 in Crohn's Disease Patients with Active Mucosal LesionsKenji Suzuki, Junji Yokoyama, Yusuke Kawauchi, et al.Gut|May 26, 2019
Immune cell trafficking and retention in inflammatory bowel disease: mechanistic insights and therapeutic advancesSebastian Zundler, Emily Becker, Lisa Lou Schulze, et al.Frontiers in Immunology|July 14, 2020
Regulation of Human Innate Lymphoid Cells in the Context of Mucosal InflammationAnja Schulz-Kuhnt, Stefan Wirtz, Markus F Neurath, et al.Journal of Clinical Medicine|February 7, 2020
Extent of Mucosal Inflammation in Ulcerative Colitis Influences the Clinical Remission Induced by VedolizumabPatrizio Scarozza, Irene Marafini, Federica Laudisi, et al.Nature Communications|February 3, 2024
Etrolizumab-s fails to control E-Cadherin-dependent co-stimulation of highly activated cytotoxic T cellsMaximilian Wiendl, Mark Dedden, Li-Juan Liu, et al.Nature Clinical Practice. Gastroenterology & Hepatology|October 28, 2006
Drug insight: novel small molecules and drugs for immunosuppressionMassimo C Fantini, Christoph Becker, Ralf Kiesslich, et al.Inflammatory Bowel Diseases|May 12, 2026
Targeting the transcription factor GATA3 by the DNAzyme formulation SB012 in patients with moderately-to-severely active ulcerative colitis: a multicenter, randomized, placebo-controlled, phase 2a induction trialRaja Atreya, Tanja Kühbacher, Michael Vieth, et al.Pageof 88